Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis
- PMID: 11606377
Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis
Abstract
Transforming growth factor beta1 (TGF-beta1) acts as a tumor suppressor at early stages of carcinogenesis, however, it has also been suggested to promote tumor progression at late stages. To determine at which stage and by what mechanisms this functional switch occurs, we have generated gene-switch-TGF-beta1 mice in which TGF-beta1 transgene expression can be induced in skin tumors at specific stages. These mice were exposed to a chemical carcinogenesis protocol, which allows tumorigenesis to develop in progressive stages from benign papillomas to malignant carcinomas. Remarkably, TGF-beta1 transgene induction in papillomas rapidly induced metastasis. This function is in sharp contrast to its tumor suppressive effect when TGF-beta1 transgene expression was induced early in the protocol. Transgenic papillomas exhibited down-regulation of TGF-beta receptors and their signal transducer, the Smads, and loss of the invasion suppressor E-cadherin/catenin complex in the cell membrane. These molecules were lost only in malignant carcinomas in control mice at a much later stage. Furthermore, transgenic papillomas exhibited elevated expression of matrix metalloproteinases and increased angiogenesis. Our study suggests that TGF-beta1 overexpression may directly induce tumor metastasis by initiating events necessary for invasion. Down-regulation of TGF-beta signaling components in tumor epithelia selectively abolishes growth inhibition, thus, switching the role of TGF-beta1 to a metastasis promoter.
Similar articles
-
Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.Cancer Res. 1999 Jun 15;59(12):2861-8. Cancer Res. 1999. PMID: 10383147
-
Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.Clin Cancer Res. 1999 Mar;5(3):711-20. Clin Cancer Res. 1999. PMID: 10100726
-
TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.Oncogene. 2002 Feb 28;21(10):1616-24. doi: 10.1038/sj.onc.1205217. Oncogene. 2002. PMID: 11896591
-
TGF beta regulation of cell proliferation.Princess Takamatsu Symp. 1994;24:250-63. Princess Takamatsu Symp. 1994. PMID: 8983080 Review.
-
The role for transforming growth factor-beta (TGF-beta) in human cancer.Crit Rev Oncog. 1999;10(4):303-60. Crit Rev Oncog. 1999. PMID: 10654929 Review.
Cited by
-
The Role of TGFβ Signaling in Squamous Cell Cancer: Lessons from Mouse Models.J Skin Cancer. 2012;2012:249063. doi: 10.1155/2012/249063. Epub 2012 Dec 26. J Skin Cancer. 2012. PMID: 23326666 Free PMC article.
-
Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer.J Proteome Res. 2006 Mar;5(3):599-610. doi: 10.1021/pr050395r. J Proteome Res. 2006. PMID: 16512675 Free PMC article.
-
Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.ISRN Dermatol. 2013 Jul 18;2013:597927. doi: 10.1155/2013/597927. eCollection 2013. ISRN Dermatol. 2013. PMID: 23984088 Free PMC article.
-
Expression of laminin 5-γ2 chain in cutaneous squamous cell carcinoma and its role in tumour invasion.Br J Cancer. 2011 Sep 6;105(6):824-32. doi: 10.1038/bjc.2011.283. Epub 2011 Aug 9. Br J Cancer. 2011. PMID: 21829200 Free PMC article.
-
Complexities of TGF-β targeted cancer therapy.Int J Biol Sci. 2012;8(7):964-78. doi: 10.7150/ijbs.4564. Epub 2012 Jul 12. Int J Biol Sci. 2012. PMID: 22811618 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Molecular Biology Databases